BACKGROUND: Local recurrence in Ewing sarcoma is associated with a poor prognosis. The purpose of the study was to determine the factors that predict local recurrence after surgical treatment of the primary tumor. METHODS: Between 1990 and 2001, 64 patients underwent surgical resection of Ewing sarcoma. Surgical margins were assessed histologically and radiologically. Response to preoperative chemotherapy was determined by detailed specimen mapping. Local recurrence-free survival (LRFS) was calculated by Kaplan-Meier analysis. Multivariate analysis was performed with the Cox proportional hazards model. RESULTS: A number of factors were found to be associated with local recurrence on univariate analysis. Patients with a good response to chemotherapy (> or = 90% tumor necrosis), had superior LRFS at 5 years (86% vs 51%, P = .015). Central site of disease was associated with an increased rate of recurrence. The LRFS at 5 years was 50% for the chest wall, 74% for pelvic/scapular, and 86% for extremity tumors (P = .083). Positive surgical margin was not a strong predictor of recurrence (P = .72). A critical analysis of minimal surgical margin based on preoperative magnetic resonance imaging (MRI) and computed tomography (CT) scans also failed to reveal an association between margin and local recurrence. In multivariate analysis, the 2 independent predictors of local recurrence were histological response to chemotherapy and central site of disease. CONCLUSION: Local recurrence after surgical resection is a complex phenomenon. An important predictive factor is the response to chemotherapy. In the current study, this seems to have the largest impact. Central site of disease may be a second independent predictive factor. (c) 2007 American Cancer Society.
BACKGROUND: Local recurrence in Ewing sarcoma is associated with a poor prognosis. The purpose of the study was to determine the factors that predict local recurrence after surgical treatment of the primary tumor. METHODS: Between 1990 and 2001, 64 patients underwent surgical resection of Ewing sarcoma. Surgical margins were assessed histologically and radiologically. Response to preoperative chemotherapy was determined by detailed specimen mapping. Local recurrence-free survival (LRFS) was calculated by Kaplan-Meier analysis. Multivariate analysis was performed with the Cox proportional hazards model. RESULTS: A number of factors were found to be associated with local recurrence on univariate analysis. Patients with a good response to chemotherapy (> or = 90% tumor necrosis), had superior LRFS at 5 years (86% vs 51%, P = .015). Central site of disease was associated with an increased rate of recurrence. The LRFS at 5 years was 50% for the chest wall, 74% for pelvic/scapular, and 86% for extremity tumors (P = .083). Positive surgical margin was not a strong predictor of recurrence (P = .72). A critical analysis of minimal surgical margin based on preoperative magnetic resonance imaging (MRI) and computed tomography (CT) scans also failed to reveal an association between margin and local recurrence. In multivariate analysis, the 2 independent predictors of local recurrence were histological response to chemotherapy and central site of disease. CONCLUSION: Local recurrence after surgical resection is a complex phenomenon. An important predictive factor is the response to chemotherapy. In the current study, this seems to have the largest impact. Central site of disease may be a second independent predictive factor. (c) 2007 American Cancer Society.
Authors: Louie L Gaston; Claudia Di Bella; John Slavin; Rodney J Hicks; Peter F M Choong Journal: Skeletal Radiol Date: 2011-02-06 Impact factor: 2.199
Authors: David Boyce-Fappiano; B Ashleigh Guadagnolo; Ravin Ratan; Wei-Lien Wang; Michael J Wagner; Shreyaskumar Patel; John A Livingston; Patrick P Lin; Kevin Diao; Devarati Mitra; Ahsan Farooqi; Alexander J Lazar; Christina L Roland; Andrew J Bishop Journal: Oncologist Date: 2020-12-14
Authors: Patrick P Lin; Mohammed D Alfawareh; Akihiko Takeuchi; Bryan S Moon; Valerae O Lewis Journal: Clin Orthop Relat Res Date: 2012-03 Impact factor: 4.176
Authors: Jennifer L Pretz; Constance M Barysauskas; Suzanne George; Jason L Hornick; Chandrajit P Raut; Yen-Lin E Chen; Karen J Marcus; Edwin Choy; Francis Hornicek; John E Ready; Thomas F DeLaney; Elizabeth H Baldini Journal: Oncologist Date: 2017-05-26
Authors: Hubert Y Pan; Ajaykumar Morani; Wei-Lien Wang; Kenneth R Hess; Arnold C Paulino; Joseph A Ludwig; Patrick P Lin; Najat C Daw; Anita Mahajan Journal: Int J Radiat Oncol Biol Phys Date: 2015-03-12 Impact factor: 7.038
Authors: Jason W Denbo; W Shannon Orr; Yanan Wu; Jianrong Wu; Catherine A Billups; Fariba Navid; Bhaskar N Rao; Andrew M Davidoff; Matthew J Krasin Journal: Ann Surg Oncol Date: 2012-07-03 Impact factor: 5.344
Authors: Jeremy Sharib; Andrew Horvai; Florette K Gray Hazard; Heike Daldrup-Link; Robert Goldsby; Neyssa Marina; Steven G DuBois Journal: Pediatr Blood Cancer Date: 2013-08-23 Impact factor: 3.167